BINA SHAH: Open Payments
NPI 1457602492 · FRISCO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,394 in 308 payments from 19 companies in 2025. Trend: 2023 $1,890 · 2024 $3,233 · 2025 $4,394
Food & beverage: $4,173Education: $221
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 37 | $702 |
| ABBVIE INC. | 31 | $463 |
| Lundbeck LLC | 28 | $452 |
| Otsuka America Pharmaceutical, Inc. | 45 | $435 |
| Neurocrine BioSciences, Inc. | 27 | $434 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $282 |
| Alkermes, Inc. | 17 | $245 |
| Collegium Pharmaceutical, Inc. | 16 | $236 |
| Janssen Pharmaceuticals, Inc | 18 | $195 |
| Corium, LLC | 12 | $187 |
Products named: REXULTI, VRAYLAR, UZEDY, INGREZZA, CAPLYTA, Jornay PM, Azstarys, Qelbree.
Industry payments across TX — which companies pay providers there.
